Ok ladies, let’s have the talk! The BIG question is, “can BCP help me with my menopause symptoms”?
If you have asked me this question, I would have replied something along the lines of…..well, it helped me!!! I have felt so blessed that I have not experienced a lot of the symptoms that many of you have or are currently experiencing. I have had blood tests done which show extremely low inflammation markers, my mood has not changed (I haven’t turned into Godzilla), my sleep has been pretty good (if I did wake up at 3 am I’d roll over go straight back to sleep). The only symptom that I have experienced is the dreaded sweats and hot flushes!!! To add, I do eat a low inflammatory diet, walk daily, exercise regularly, and I drink plenty of water. But in combination with these lifestyle habits, I do think that BCP has definitely contributed to my lack of and / or reduced symptoms.
Menopausal symptoms can be a challenge to manage, and we are all unique in our own way, but let’s take a look at what we know about Beta Caryophyllene (BCP) and how it might offer some sweet relief during this significant stage of life.
A quick re-cap first for all of our newcomers:
BCP is a sesquiterpene compound that belongs to the class of terpenes, which are aromatic hydrocarbons found in various plants, especially in cannabis, black pepper, and cloves. It is notable for its interaction with the endocannabinoid system (ECS), a complex cell-signaling system that plays a crucial role in regulating various physiological processes.
The Endocannabinoid System and Menopause:
The ECS comprises receptors (CB1 and CB2 receptors), endocannabinoids produced by the body, and enzymes responsible for their synthesis and degradation. Research suggests that the ECS may influence hormonal balance, and alterations in its functioning might contribute to the manifestation of menopausal symptoms. Basically, this just means – keep your ECS functioning optimally, the less menopausal symptoms you may experience.
Beta-caryophyllene and CB2 Receptors:
BCP is unique among terpenes because it selectively interacts with CB2 receptors, primarily found in the immune and peripheral tissues. CB2 receptors play a crucial role in modulating inflammation and immune responses.
Potential Benefits for Menopausal Symptoms:
- Anti-Inflammatory Properties: BCP has demonstrated anti-inflammatory effects by interacting with CB2 receptors. Menopausal symptoms, such as hot flashes, muscle and joint pain, often have an inflammatory component. By reducing inflammation, BCP may contribute to alleviating these discomforts.
- Mood Regulation: Menopause is frequently associated with mood swings, anxiety, and depression. BCP’s interaction with CB2 receptors could potentially contribute to mood stabilisation. The release of endorphins (our feel good hormone) also helps our mood to be lifted and a general sense of wellbeing may be experienced.
- Bone Health: Hormonal changes during menopause can lead to a decline in bone density, increasing the risk of osteoporosis. Some studies suggest that the ECS is involved in bone metabolism. BCP’s anti-inflammatory effects and potential influence on the ECS could contribute to maintaining bone health.
While the research on beta-caryophyllene and menopause as a whole, is virtually non-existent, we can find a lot of research on the individual symptoms separately. We all know that our individual responses to BCP may vary, but it’s great to at least know that there is potential for some of our menopausal symptoms.
So try and stay cool ladies, and up your doses if needed!!!
Have a wonderful week!
INFLAMMATION: https://www.canna-oils.com.au/cytokine-expression/; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692661/
CB2 RECEPTORS: https://www.canna-oils.com.au/cb2-receptors-a-gateway-to-pain-relief/
Disclaimer: The information in this post is for reference purposes only and not intended to constitute or replace professional medical advice or personal research. Please consult a qualified medical professional before making any changes to your diet, medications or lifestyle. Effects are provided as a guide only. Statements have not been evaluated by the TGA.